← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2022Last known activity
Oct 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (8)
- NCT06490731Lead sponsorPhase 1/Phase 2Oct 1, 2024
- NCT06490731Sponsor investigatorPhase 1/Phase 2Oct 1, 2024
- NCT06997562Lead sponsorN/AMay 1, 2024
- NCT06997562Sponsor investigatorN/AMay 1, 2024
- NCT05705128Lead sponsorPhase 2/Phase 3Aug 1, 2023
- NCT05705128Sponsor investigatorPhase 2/Phase 3Aug 1, 2023
- NCT06451406Lead sponsorN/AOct 1, 2022
- NCT06451406Sponsor investigatorN/AOct 1, 2022
Details
- Last known activity
- Oct 1, 2024